Skip to main content
Amgen Inc. (AMGN)
NASDAQ: AMGN · Real-Time Price · USD
280.06
-1.16 (-0.41%)
May 5, 2025, 4:00 PM EDT - Market closed

Amgen Revenue by Type
Period Ending Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 3, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018
Product Sales
32.78B 32.03B 31.14B 29.54B 28.18B 26.91B 25.63B 25.32B
Product Sales Growth
16.32% 19.01% 21.51% 16.68% 13.11% 8.50% 4.52% 2.91%
Other
1.34B 1.40B 1.39B 1.39B 1.35B 1.28B 1.20B 1.26B
Other Growth
-0.44% 9.14% 15.45% 10.21% 5.97% -15.90% -33.48% -29.03%

Product Sales by Geography
Period Ending Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 3, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018
United States
23.99B 23.30B 22.66B 21.37B 20.27B 19.27B 18.20B 17.97B
United States Growth
18.35% 20.91% 24.54% 18.94% 14.64% 8.62% 4.57% 2.74%
Rest of World
8.79B 8.73B 8.48B 8.17B 7.91B 7.64B 7.43B 7.35B
Rest of World Growth
11.11% 14.23% 14.10% 11.15% 9.36% 8.22% 4.40% 3.32%

Operating Expense Breakdown
Period Ending Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 3, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018
Selling, General, and Administrative
6.98B 7.10B 7.49B 7.22B 6.73B 6.18B 5.48B 5.41B
Selling, General, and Administrative Growth
3.66% 14.84% 36.79% 33.43% 23.60% 14.13% 3.99% 2.38%
Research and Development
6.11B 5.96B 5.77B 5.40B 5.07B 4.78B 4.57B 4.61B
Research and Development Growth
20.48% 24.67% 26.24% 17.28% 11.82% 7.89% 2.60% -3.38%
Other Expenses
973.00M 248.00M 192.00M 765.00M 836.00M 879.00M 840.00M 201.00M
Other Expenses Growth
16.39% -71.79% -77.14% 280.60% 26.48% 74.75% 42.86% -65.04%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.